Nutex Health (NASDAQ:NUTX) Stock Price Down 4.7% – Should You Sell?

Nutex Health Inc. (NASDAQ:NUTX)’s share price dropped 4.7% during trading on Wednesday . The company traded as low as $118.50 and last traded at $120.4580. Approximately 89,092 shares changed hands during mid-day trading, a decline of 54% from the average daily volume of 192,946 shares. The stock had previously closed at $126.39.

Wall Street Analyst Weigh In

NUTX has been the topic of a number of research reports. Wall Street Zen upgraded Nutex Health from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. Weiss Ratings upgraded Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a report on Monday, May 4th. One analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, Nutex Health has an average rating of “Moderate Buy” and an average target price of $205.00.

Nutex Health Trading Down 3.9%

The firm has a market capitalization of $835.31 million, a PE ratio of 9.38 and a beta of 0.25. The company has a debt-to-equity ratio of 0.66, a quick ratio of 3.12 and a current ratio of 3.14. The firm has a fifty day moving average of $107.37 and a 200 day moving average of $127.79.

Nutex Health (NASDAQ:NUTX) last issued its quarterly earnings data on Thursday, April 30th. The company reported $6.52 earnings per share for the quarter, beating analysts’ consensus estimates of $3.99 by $2.53. Nutex Health had a return on equity of 23.50% and a net margin of 10.95%.The firm had revenue of $216.49 million during the quarter, compared to analyst estimates of $227.80 million.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the company. Deutsche Bank AG boosted its position in Nutex Health by 3.9% during the 4th quarter. Deutsche Bank AG now owns 2,633 shares of the company’s stock valued at $433,000 after purchasing an additional 98 shares during the period. Russell Investments Group Ltd. boosted its stake in Nutex Health by 1.4% during the fourth quarter. Russell Investments Group Ltd. now owns 8,706 shares of the company’s stock valued at $1,433,000 after buying an additional 116 shares in the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al boosted its stake in Nutex Health by 3.7% during the fourth quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 5,600 shares of the company’s stock valued at $922,000 after buying an additional 200 shares in the last quarter. Islay Capital Management LLC bought a new stake in Nutex Health in the fourth quarter worth about $34,000. Finally, First Trust Advisors LP lifted its holdings in Nutex Health by 2.4% in the 4th quarter. First Trust Advisors LP now owns 11,461 shares of the company’s stock valued at $1,887,000 after acquiring an additional 272 shares during the last quarter. Institutional investors and hedge funds own 5.32% of the company’s stock.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight?loss services and behavioral health support. By combining in?person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost?effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail?anchored centers, offering treatment for non?life?threatening injuries and illnesses, preventive screenings and basic primary care.